Y-Intercept (HK)
COGT icon

Y-Intercept (HK)’s Cogent Biosciences COGT Stock Holding History

Y-Intercept (HK)’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-48,220
Closed -$1.87M – 1644
2026
Q2 		$1.87M Buy
48,220
+13,461
+39% +$471K 0.04% 745
2026
Q1 		$1.34M Sell
34,759
-60,045
-63% -$2.22M 0.03% 914
2025
Q4 		$3.37M Buy
+94,804
New +$2.67M 0.08% 374
2025
Q3 		– Sell
-116,127
Closed -$834K – 1628
2025
Q2 		$834K Buy
116,127
+72,628
+167% +$403K 0.02% 1020
2025
Q1 		$261K Sell
43,499
-31,538
-42% -$247K 0.02% 953
2024
Q4 		$585K Buy
75,037
+43,472
+138% +$433K 0.04% 657
2024
Q3 		$341K Sell
31,565
-13,294
-30% -$129K 0.02% 957
2024
Q2 		$378K Buy
+44,859
New +$340K 0.02% 940
2024
Q1 		– Sell
-14,618
Closed -$86K – 1419
2023
Q4 		$86K Buy
+14,618
New +$112K 0.01% 1116

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Harbor Investment Advisory
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Armstrong Advisory Group
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Y-Intercept (HK)'s COGT Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Cogent Biosciences (COGT) in Q3 2026, closing a stake of 48,220 shares — an estimated $1.87M sold.

Y-Intercept (HK) first reported a position in COGT in Q4 2023 and held it in 9 quarters. The position peaked at $3.37M in Q4 2025. 21 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Cogent Biosciences position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 48,220 Cogent Biosciences shares in Q3 2026, an estimated $1.87M.
  • Y-Intercept (HK) first reported a position in Cogent Biosciences in Q4 2023 and held it in 9 quarters.
  • Y-Intercept (HK)'s Cogent Biosciences position peaked at $3.37M in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.